Anti-IL31, AlpHcAbs® Human antibody

Details and Advantages

Code: 300-665-001

Size: 100ug

Applications: ELISA,Flow Cyt

Specificity: Human

Conjugate: Unconjugated

Advantages:

High lot-to-lot consistency

Increased sensitivity and higher affinity

Animal-free production

Inquire Now

Next Product

Product Description Manual MSDS FAQ Citations

Description:
Anti-IL31, AlpHcAbs® Human antibody is designed for detecting human IL31 specifically. Based on ELISA and/or FCM, Anti-IL31, AlpHcAbs® Human antibody reacts with human IL31 specifically.

Immunogen: Recombinant human IL31
Host: Alpaca pacous
Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Human IL31
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% Glycerol
Storage: Store at –20 °C, (Avoid freeze / thaw cycles)

Background:
Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

Application:

ELISA: 1:4,000-1:10000
Flow Cytometry: 1:200-1:1000
Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.

FAQ

Citations